| P2093 | author name string | Canonica GW | |
| | Passalacqua G | |
| | Baiardini I | |
| P2860 | cites work | The work impact of asthma and rhinitis: findings from a population-based survey | Q24853247 |
| | The MOS 36-ltem Short-Form Health Survey (SF-36) | Q26778425 |
| | Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee | Q29615468 |
| | Quality of life in adults and children with allergic rhinitis | Q33953556 |
| | Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. | Q35112407 |
| | The economic burden of allergic rhinitis: a critical evaluation of the literature. | Q35751676 |
| | Quality of life scales in allergic rhinitis | Q35764423 |
| | An update on the asthma-rhinitis link | Q35764427 |
| | The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? | Q35804457 |
| | Mechanisms of immunotherapy. | Q35811876 |
| | Development and validation of a new health-related quality of life instrument for patients with sinusitis | Q36209097 |
| | Pilot study of outcomes in pediatric rhinosinusitis | Q39473884 |
| | Measuring health-related quality of life | Q40885951 |
| | Impact of upper respiratory allergic diseases on quality of life | Q41720296 |
| | Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dip | Q44028519 |
| | Effects of budesonide and fluticasone propionate in a placebo-controlled study on symptoms and quality of life in seasonal allergic rhinitis. | Q44051945 |
| | Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis | Q45103521 |
| | Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments | Q45280010 |
| | Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr. | Q46903579 |
| | A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis | Q48633141 |
| | Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis | Q48911545 |
| | Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis | Q49075893 |
| | Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. | Q51136540 |
| | Impact of functional endoscopic sinus surgery on symptoms and quality of life in chronic rhinosinusitis. | Q51724412 |
| | Can the standard gamble and rating scale be used to measure quality of life in rhinoconjunctivitis? Comparison with the RQLQ and SF-36. | Q51958771 |
| | Distinguishing between quality of life and health status in quality of life research: a meta-analysis. | Q51981856 |
| | Health-related quality of life assessment in young adults with seasonal allergic rhinitis. | Q53490994 |
| | Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. | Q53535146 |
| | Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. | Q53543750 |
| | Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. | Q53553276 |
| | Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index. | Q53555320 |
| | Quality of life during formoterol treatment: comparison between asthma-specific and generic questionnaires. Canadian and the Dutch Formoterol Investigators. | Q53571484 |
| | Measuring quality of life in children with rhinoconjunctivitis. | Q53582108 |
| | Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. | Q53619972 |
| | Measuring quality of life in children with asthma. | Q53627974 |
| | Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. | Q53659322 |
| | Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures. | Q54420300 |
| P921 | main subject | rhinosinusitis | Q2148123 |
| P304 | page(s) | 40-45 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | Pediatric Allergy & Immunology | Q14064731 |
| P1476 | title | Rhinitis, rhinosinusitis and quality of life in children | |
| P478 | volume | 18 Suppl 18 | |